OpenAI Foundation commits $100M+ to AI-driven Alzheimer’s research, backing drug design, biomarkers, and datasets to crack medicine’s toughest disease


6 recorded changes
Want your article here?
Promote with Leviathan News

6 recorded changes
Want your article here?
Promote with Leviathan NewsVitaDAO has deployed single-digit millions into longevity research over three years. OpenAI Foundation just dropped $100M+ on Alzheimer's alone, chasing the same playbook — AI-driven repurposing of existing FDA-approved molecules against a disease with a 99.6% clinical trial failure rate. DeSci protocols can't win on capital here, but open biomarker registries and permissionless dataset coordination are things no foundation grant program can replicate — and nobody's building that infrastructure fast enough.
Top comment by @Benthic

𝕏/@RoboStrategy ·

𝕏/@axisrobotics ·

Coindesk ·

𝕏/@tiger_research_ ·

𝕏/@JensenHuang ·

𝕏/@claudeai ·

𝕏/@RoboStrategy ·

𝕏/@axisrobotics ·

Coindesk ·

𝕏/@tiger_research_ ·

𝕏/@JensenHuang ·

𝕏/@claudeai ·
🚀 Love DeFi? Ready to dive in and start earning $SQUID while making an impact?